Table 2.
Generic Core Scale | p-value | Cancer Module | p-value | Multidimensional Fatigue Module | p-value | ||||
---|---|---|---|---|---|---|---|---|---|
Argentina mean (sd) | Sweden mean (sd) | Argentina mean (sd) | Sweden mean (sd) | Argentina mean (sd) | Sweden mean (sd) | ||||
Gender | |||||||||
Female | 68.8(11.0) | 65.3(19.3) | 0.58 | 69.6(12.1) | 74.7(15.6) | 0.30 | 77.1(14.2) | 63.8(15.4) | 0.07 |
Male | 66.0(13.3) | 62.2(12.3) | 0.96 | 70.4(11.2) | 67.9(22.6) | 0.06 | 75.5(13.8) | 56.7(16.8) | 0.01 |
Age groups | |||||||||
5 to 12 years | 70.9(11.3) | 78.3(11.9) | 0.20 | 66.8(12.2) | 85.5(5.9) | p < 0.0001 | 77.9(14.4) | 69.8(11.5) | 0.17 |
13 to 18 years | 63.5(12.6) | 47.6(15.9) | 0.02 | 73.1(9.9) | 56.0(18.1) | 0.08 | 74.4(13.3) | 50.0(14.1) | 0.002 |
Diagnostic groups | |||||||||
Leukaemia | 68.4(12.3) | 70.4(20.8) | 0.05 | 73.2(8.7) | 80.6(22.1) | 0.06 | 77.0(13.5) | 65.7(16.7) | 0.17 |
Solid tumours | 66.7(15.3) | 56.4(18.2) | 0.36 | 70.6(7.7) | 64.3(19.6) | 0.79 | 79.1(15.1) | 51.9(12.0) | 0.009 |
CNS tumours | 59.8(1.5) | 75.5(25.8) | 0.80 | 50.5(17.7) | 77.4(5.9) | 0.20 | 63.2(6.2) | 78.3(5.8) | 0.10 |
Treatment modality | |||||||||
Chemotherapy | 70.0(12.4) | 60.8(21.5) | 0.24 | 73.8(8.3) | 70.8(24.3) | 0.70 | 80.7(11.4) | 57.3(18.6) | 0.003 |
Combined therapy | 58.7(7.8) | 67.2(20.4) | 0.58 | 59.6(12.7) | 72.4(14.8) | 0.06 | 63.2(11.3) | 64.0(12.7) | 0.92 |
Note: Scores range from 0 to 100; higher scores represent a better HRQOL. Significant differences are highlighted in bold type
sd standard deviation